Not applicableWithdrawnNCT01811810What this trial is testingProton Therapy for High Risk Prostate CancerWho this might be right forProstate Cancer Abramson Cancer Center at Penn Medicine
Not applicableNot Yet RecruitingNCT07158892What this trial is testingUnderstanding Patient Preferences When Deciding on a Voluntary Musculoskeletal TestWho this might be right forNon-traumatic Musculoskeletal ConditionsCarpal Tunnel Syndrome (CTS)Lateral Epicondylitis+5 more University of Texas at Austin 220
Large-scale testing (Phase 3)Study completedNCT00928486What this trial is testingA Safety Confirmation Study on Lenalidomide With Dexamethasone In Japanese Patients With Previously Treated Multiple MyelomaWho this might be right forMultiple Myeloma Celgene 25
Early research (Phase 1)UnknownNCT00688116What this trial is testingStudy of STA-9090, Administered Twice-Weekly in Patients With Solid TumorsWho this might be right forSolid Tumors Synta Pharmaceuticals Corp. 45
Early research (Phase 1)Study completedNCT01189929What this trial is testingGemcitabine and Demcizumab (OMP-21M18) With or Without Abraxane® as 1st-line Treatment in Subjects With Locally Advanced or Metastatic Pancreatic CancerWho this might be right forPancreatic Cancer OncoMed Pharmaceuticals, Inc. 57
Not applicableUnknownNCT04440605What this trial is testingConfirm the Accuracy of Locally Advanced Gastric Cancer DiagnosisWho this might be right forGastric CancerGastric Cancer StageCT+1 more Peking University 968
Testing effectiveness (Phase 2)UnknownNCT05816694What this trial is testingThe Efficacy and Safety of Nanoparticle Albumin-bound (NAB)-Paclitaxel Plus Cisolation Versus CEP (Cisplatin, Epirubicin,Cyclophosphamide) in Induction Therapy for Thymoma: a Study for a Single-center Prospective Phase II Randomized Controlled Train.Who this might be right forHistological or Cytological Confirmed Stage Ⅲ and Ⅳa Thymoma Peng Liu 50
Early research (Phase 1)Study completedNCT02510001What this trial is testingMEK and MET Inhibition in Colorectal CancerWho this might be right forSolid TumorColorectal Cancer University of Oxford 82
Not applicableUnknownNCT01467024What this trial is testingEvaluation of the MP Diagnostics HTLV Blot 2.4Who this might be right forHTLV-I InfectionsHTLV-II InfectionsHuman T-lymphotropic Virus 1+3 more MP Biomedicals, LLC 600
Testing effectiveness (Phase 2)Study completedNCT05140382What this trial is testingAZD4573 as Monotherapy or in Combinations With Anti-cancer Agents in Patients With r/r PTCL or r/r cHLWho this might be right forRelapsed/Refractory Peripheral T-cell LymphomaRelapsed/Refractory Classical Hodgkins Lymphoma AstraZeneca 52
Testing effectiveness (Phase 2)Looking for participantsNCT05243212What this trial is testingStudy of CAR-BCMA, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against BCMA in Subjects With Multiple MyelomaWho this might be right forMultiple MyelomaRelapse Multiple Myeloma Sheba Medical Center 75
Testing effectiveness (Phase 2)Study completedNCT01987102What this trial is testingInvestigation of [6R] 5,10-methylenetetrahydrofolate (Arfolitixorin) as Rescue Therapy for Osteosarcoma Patients Treated With HDMTX.Who this might be right forOsteosarcoma Isofol Medical AB 18
Large-scale testing (Phase 3)Looking for participantsNCT07100730What this trial is testingStudy of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent GlioblastomaWho this might be right forNeoplastic DiseaseGlioblastomaGlioblastoma (GBM)+3 more Telix Pharmaceuticals (Innovations) Pty Limited 50
Not applicableLooking for participantsNCT07696832What this trial is testingEfficacy and Safety of Ivonescimab Monotherapy as First-Line Treatment for PD-L1-Positive, Driver Gene-Negative, Locally Advanced or Metastatic NSCLC: A Multicenter, Prospective, Real-World Cohort StudyWho this might be right forPatients Must Have Histologically or Cytologically Confirmed Locally Advanced or Metastatic NSCLCEGFR Mutation-negative and ALK Rearrangement-negativeEastern Cooperative Oncology Group Performance Status (ECOG PS) Score of 0 to 2+2 more Guangdong Association of Clinical Trials
Not applicableActive Not RecruitingNCT03208374What this trial is testingExercise Exposure Data Collection in Patients Undergoing Tumor Molecular ProfilingWho this might be right forCancerCarcinoma Memorial Sloan Kettering Cancer Center 1,600
Not applicableNot Yet RecruitingNCT05480189What this trial is testingEffect of Zoledronic Acid Treatment on Bone-related Events in Breast Cancer Patients With Bone Metastases: a Prospective, Multicenter, Real-world StudyWho this might be right forHistologically Confirmed Breast Cancer ,Diagnosis of Bone Metastasis Zhejiang Cancer Hospital 1,000
Testing effectiveness (Phase 2)Study completedNCT04470726What this trial is testingSafety and Efficacy Evaluation of AIV001 in Nonmelanoma Skin Cancer of the Low Risk Basal Cell Carcinoma SubtypeWho this might be right forSuperficial Basal Cell CarcinomaNodular Basal Cell CarcinomaNonmelanoma Skin Cancers AiViva BioPharma, Inc. 26
Early research (Phase 1)Study completedNCT00736372What this trial is testingA Trial of PX-12 in Patients With a Histologically or Cytologically Confirmed Diagnosis of Advanced or Metastatic CancerWho this might be right forMetastatic CancerAdvanced Cancer Cascadian Therapeutics Inc. 14
Not applicableStudy completedNCT01278147What this trial is testingCancer Fatigue Education ProgramWho this might be right forPatient With Histologically Confirmed Malignancy Institut de Cancérologie de la Loire 200
Early research (Phase 1)Study completedNCT00338026What this trial is testingA Phase I Study of ECO-4601 in Patients With Advanced CancerWho this might be right forTumorsGliomaColorectal Cancer+5 more Thallion Pharmaceuticals 26